Coronary endothelial dysfunction and impaired microcirculation response to atrial natriuretic peptide in

Takashi Ashikaga1, Mitsuhiro Nishizaki, Hiroyuki Fujii

  • 1Department of Cardiology, Yokohama Minami Kyosai Hospital, 1-21-1 Mutsuurahigashi, Kanazawa-ku, Yokohama City, Kanagawa 236-0037, Japan. ashikaga-ind@umin.ac.jp

Insights

Hyperinsulinemia (HI) is linked to endothelial dysfunction. In patients with HI, atrial natriuretic peptide response in coronary microcirculation is significantly blunted, suggesting a pathological effect even in mild cases.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • Endothelial dysfunction is a known complication of hyperinsulinemia (HI).
  • Assessing coronary microcirculation responses to vasoactive agents is crucial for understanding vascular health in patients with normal coronary arteries.

Purpose of the Study:

  • To investigate coronary microcirculation responses to various vasoactive agents in patients with normoinsulinemia (NI) versus hyperinsulinemia (HI).
  • To evaluate the impact of HI on endothelial function and microvascular reactivity.

Main Methods:

  • 57 patients with angiographically normal coronary arteries were divided into NI (n=37) and HI (n=20) groups based on an oral glucose tolerance test.
  • Epicardial artery vasoactivity was assessed using acetylcholine chloride.
  • Coronary microcirculation function was evaluated via intracoronary administration of adenosine triphosphate, isosorbide dinitrate, and atrial natriuretic peptide.

Main Results:

  • Epicardial artery vasoconstriction to acetylcholine was mildly reduced in the HI group (P = .04).
  • Coronary flow reserve to adenosine triphosphate was similar between NI and HI groups.
  • In the HI group, the response of peak velocity to atrial natriuretic peptide was significantly blunted compared to isosorbide dinitrate (P < .001), unlike in the NI group.

Conclusions:

  • Hyperinsulinemia is associated with mild endothelial dysfunction affecting epicardial arteries.
  • Atrial natriuretic peptide response is significantly impaired in the coronary microcirculation of patients with HI, even with mild endothelial dysfunction.
  • These findings suggest a potential pathological role for atrial natriuretic peptide in HI-related microvascular impairment.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...